Which are the causes of Congenital Adrenal Hyperplasia (CAH)?

Congenital Adrenal Hyperplasia (CAH) is a group of inherited genetic disorders caused by mutations in genes that encode enzymes necessary for the adrenal glands to produce cortisol. Because the body cannot produce sufficient cortisol, it overcompensates by overproducing androgens, leading to the clinical manifestations of Congenital Adrenal Hyperplasia (CAH).

What is the genetic basis of Congenital Adrenal Hyperplasia (CAH)?

Congenital Adrenal Hyperplasia (CAH) is caused by a deficiency in one of several enzymes required for cortisol synthesis. The most common form, accounting for approximately 90-95% of cases, is 21-hydroxylase deficiency, caused by mutations in the CYP21A2 gene. This condition follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease.

What triggers the symptoms of Congenital Adrenal Hyperplasia (CAH)?

The primary mechanism driving Congenital Adrenal Hyperplasia (CAH) is a disrupted feedback loop in the endocrine system. Normally, the pituitary gland monitors cortisol levels. In Congenital Adrenal Hyperplasia (CAH), the adrenal glands cannot produce enough cortisol, signaling the pituitary to release more ACTH (adrenocorticotropic hormone). This constant stimulation causes the adrenal glands to enlarge (hyperplasia) and produce excess androgens. Key factors include:

• Genetic mutations: Specific variants in the CYP21A2 gene.


• Enzyme deficiency: The inability to convert precursors into functional cortisol.


• Androgen excess: The biochemical byproduct of the adrenal glands' overstimulation.

Is the cause of Congenital Adrenal Hyperplasia (CAH) fully understood?

While the genetic etiology of Congenital Adrenal Hyperplasia (CAH) is well-mapped, researchers are still investigating the long-term impact of prenatal androgen exposure and the variability in phenotype expression between individuals with the same genotype. Current research focuses on gene therapy and improving the precision of hormone replacement therapies to better mimic the body's natural circadian rhythm.

Next steps

• Consult a pediatric endocrinologist for specialized management of Congenital Adrenal Hyperplasia (CAH).


• Connect with the 81 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Speak with a clinical geneticist to discuss family planning and carrier testing options.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Congenital Adrenal Hyperplasia.


• Orphanet: Congenital Adrenal Hyperplasia.


• OMIM (Online Mendelian Inheritance in Man): CYP21A2 gene entry.


• The CARES Foundation (Congenital Adrenal Hyperplasia Research, Education & Support).